Showing results (1681-1690 of 1,900) with videos related to

Sort By:
Pageof 190
Frontiers in Immunology|August 2, 2021
Safety and Immunogenicity of ChAd63/MVA Pfs25-IMX313 in a Phase I First-in-Human TrialHans de Graaf, Ruth O Payne, Iona Taylor, et al.
Blood|February 14, 2014
A phase 1 clinical trial of long-term, low-dose treatment of WHIM syndrome with the CXCR4 antagonist plerixaforDavid H McDermott, Qian Liu, Daniel Velez, et al.
Journal of Medicinal Chemistry|February 20, 2009
Inhibitors of hepatitis C virus polymerase: synthesis and biological characterization of unsymmetrical dialkyl-hydroxynaphthalenoyl-benzothiadiazinesRolf Wagner, Daniel P Larson, David W A Beno, et al.
Biorxiv : the Preprint Server for Biology|September 26, 2025
A cross model spatial and single-cell atlas reveals the conserved involvement of osteopontin in polycystic kidney diseaseSarah J Miller, Hua Zhong, Weidong Wu, et al.
Global Change Biology|August 18, 2021
Wealth and urbanization shape medium and large terrestrial mammal communitiesSeth B Magle, Mason Fidino, Heather A Sander, et al.
Vaccine|May 23, 2026
Evaluation of EcoCRM, virus-like particles, and mRNA as vaccine platforms against Borrelia burgdorferiCarleena M Rocuskie-Marker, Annalisa B Huckaby, Olivia M Conaway, et al.
Disease Models & Mechanisms|March 21, 2025
Microvascular aberrations found in human polycystic kidneys are an early feature in a Pkd1 mutant mouse modelDaniyal J Jafree, Charith Perera, Mary Ball, et al.
Plos One|July 30, 2011
Impact on malaria parasite multiplication rates in infected volunteers of the protein-in-adjuvant vaccine AMA1-C1/Alhydrogel+CPG 7909Christopher J A Duncan, Susanne H Sheehy, Katie J Ewer, et al.
Plos One|October 18, 2011
Adenovirus 5-vectored P. falciparum vaccine expressing CSP and AMA1. Part A: safety and immunogenicity in seronegative adultsMartha Sedegah, Cindy Tamminga, Shannon McGrath, et al.
The Lancet. Infectious Diseases|December 13, 2024
Safety and efficacy of the blood-stage malaria vaccine RH5.1/Matrix-M in Burkina Faso: interim results of a double-blind, randomised, controlled, phase 2b trial in childrenHamtandi M Natama, Jo Salkeld, Athanase Somé, et al.
Pageof 190